• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Marksans Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3285.0
  • ISIN : INE750C01026
250.65 -7 (-2.83%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    249.00

  • Today’s High

    258.00

  • Open

    258.00

  • Perv Close

    257.95

  • 52W Low

    157.06

  • 52W High

    358.70

Key Indicators

  • P/E(TTM)

    60.34

  • Mar.Cap (₹Cr.)

    11,358.55

  • Div & Yield %

    0.32

  • Book Value(₹)

    30.53

  • Debt-Equity Ratio

    -2.83

  • AGM Date

    17-Jun-2025

  • EPS

    4.15

  • P/E Ratio

    60.34

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    11,358.55

  • RONW (%)

    16.53

  • ROCE (%)

    20.78

Score Board

  • Equity (₹ in Cr.)

    45.32

  • BV (₹)

    30.50

  • Sales( ₹ in Cr.)

    1,174.37

  • NP (in Cr.)

    188.27

  • NP Var(%)

    41.0

  • Div%

    80.0

  • CPS (₹)

    4.80

  • EPS (₹)

    4.20

  • Traded Value (₹ in Lakhs)

    11,693.89

  • 52 Week High

    358.70

  • 52 Week Low

    157.06

  • Price BSE

    258.0

  • Price NSE

    258.00

  • Market Capital( in Cr.)

    11,693.89

  • P/C Ratio

    53.70

  • P/E Ratio

    62.10

  • Price Vs.BV

    4.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 853.27 655.20 658.29 599.55 433.42 424.16
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 853.27 655.20 658.29 599.55 433.42 424.16
Other Income 62.07 60.48 42.25 31.16 0.17 7.93
Stock Adjustments 7.25 10.19 -3.89 -0.55 5.63 2.71
Total Income 922.59 725.87 696.65 630.16 439.22 434.80
EXPENDITURE :            
Raw Materials 486.18 404.64 373.70 337.36 251.04 239.05
Power and Fuel Cost 26.04 14.24 11.49 10.90 8.68 8.22
Employee Cost 77.19 56.09 60.46 54.64 48.51 46.33
Other Manufacturing Expenses 41.61 21.09 5.25 6.98 4.76 8.38
Selling and Administration Expenses 81.00 61.54 67.57 60.08 43.86 47.18
Miscellaneous Expenses 8.56 15.89 22.22 15.31 10.70 14.38
Employee Benefit Expenses 77.19 56.09 60.46 54.64 48.51 46.33
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 720.58 573.49 540.68 485.28 367.55 363.54
Operating Profit 202.01 152.38 155.97 144.87 71.66 71.26
Interest 0.99 3.61 3.80 5.35 7.29 6.56
Gross Profit 201.02 148.77 152.17 139.52 64.37 64.70
Depreciation 29.13 16.74 17.66 15.19 11.64 8.69
Profit Before Tax 171.89 132.03 134.51 124.33 52.73 56.01
Current Tax 37.46 29.34 30.02 28.19 11.15 11.39
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.68 -0.17 0.50 -2.24 3.68 1.00
Reported Net Profit 133.76 102.87 103.99 98.38 37.90 43.62
Extraordinary Items 0.07 -0.05 0.00 0.03 0.03 -0.03
Adjusted Net Profit 133.69 102.92 103.99 98.35 37.87 43.65
Adjustment below Net Profit 0.28 -8.64 0.05 -0.20 -0.39 0.03
P & L Balance brought forward 233.61 155.21 61.41 -32.69 -62.74 -104.34
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 22.66 15.82 10.23 4.09 7.47 2.05
P & L Balance carried down 345.00 233.61 155.21 61.41 -32.69 -62.74
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 60.00 50.00 25.00 25.00 10.00 5.00
Dividend Per Share(Rs) 0.60 0.50 0.25 0.25 0.10 0.05
Earnings Per Share-Unit Curr 2.95 2.27 2.54 2.40 0.93 1.07
Earnings Per Share(Adj)-Unit Curr 2.95 2.27 2.54 2.40 0.93 1.07
Book Value 26.98 24.52 16.90 14.65 12.35 11.50
Book Value(Adj)-Unit Curr 26.98 24.52 16.90 14.65 12.35 11.50

Shareholding Pattern

  • Promoter Group

    43.87%

  • Public Share Holding

    56.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 198,822,009 43.87 198,822,009 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 198,822,009 43.87 198,822,009 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 49,324,324 10.88 49,324,324 1
Financial Institutions / Banks 2,911 0.00 911 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 51,286,765 11.32 51,286,765 134
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 15,293,537 3.37 15,293,537 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,359,741 1.18 5,359,741 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 121,267,278 26.76 121,265,278 153
2] Non Institution
Bodies Corporate 5,881,787 1.30 5,880,787 718
Clearing Members 94,482 0.02 94,482 40
Directors of their Relatives 0 0.00 0 0
Employees 4,265 0.00 4,265 7
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,136,823 1.35 6,136,823 4,207
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,318,906 0.73 3,318,906 2,589
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 17,217,353 3.80 17,217,353 30
Individuals holding nominal share capital up to Rs. 1 lakh 99,584,499 21.98 99,319,679 249,522
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,455 0.00 3,455 3
Others 827,790 0.18 827,790 1
Sub Total 133,074,459 29.37 132,808,639 257,118
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 453,163,746 100.00 452,895,926 257,273

Company Background

Marksans Pharma LtdPharmaceuticals - Indian - Formulations

  • Marksans Pharma Ltd
  • BSE Code : 3285.0
  • ISIN : INE750C01026

  • Incorporation Year

    1992

  • Registered Office

    11th Flr GRANDEUR Oshiwara
    Veera Desai Extn Rd Andheri(W), Mumbai,
    Maharashtra-400053

  • Telephone

    91-22-40012000

  • FAX

    91-22-40012011

  • Chairman

    Mark Saldanha

  • Managing Director

    Mark Saldanha

  • Company Secretary

    Harshavardhan Panigrahi

  • Auditor

    MSKA & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Marksans Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Marksans Pharma 250.40 915.35 853.27 60.34 14.67
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92